A Multicriteria Decision Analysis Comparing Pharmacotherapy for Chronic Neuropathic Pain, Including Cannabinoids and Cannabis-Based Medical Products-Reference-Cited by-同舟云学术

A Multicriteria Decision Analysis Comparing Pharmacotherapy for Chronic Neuropathic Pain, Including Cannabinoids and Cannabis-Based Medical Products

Published:2021-03-17 Issue: Volume: Page:
ISSN:2578-5125
Container-title:Cannabis and Cannabinoid Research
language:en
Short-container-title:Cannabis and Cannabinoid Research

Author:

Nutt David J.¹,Phillips Lawrence D.²,Barnes Michael P.³,Brander Brigitta⁴,Curran Helen Valerie⁴,Fayaz Alan⁴,Finn David P.⁵,Horsted Tina⁶,Moltke Julie⁶,Sakal Chloe⁷,Sharon Haggai⁸,O'Sullivan Saoirse E.⁹,Williams Tim¹⁰,Zorn Gregor¹¹,Schlag Anne K.⁷

Affiliation:

1. Department of Brain Sciences, Faculty of Medicine, Imperial College London, London, United Kingdom.

2. Department of Management, Emeritus Professor of Decision Science, London School of Economics and Political Science, London, United Kingdom.

3. Medical Cannabis Clinicians' Society, London, United Kingdom.

4. University College London, London, United Kingdom.

5. National University of Ireland, Galway, Ireland.

6. Clinic Horsted, Copenhagen, Denmark.

7. Drug Science, London, United Kingdom.

8. Sagol Brain Institute, Tel-Aviv, Israel.

9. CanPharmaConsulting, Nottingham, United Kingdom.

10. AWP Mental Health NHS Trust, Bristol, United Kingdom.

11. European Cannabinoid Therapy Association, Worcester, United Kingdom.